DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease

MANUFACTURER: Theravance Biopharma

USAGE: Oral

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Yupelri is a medication with the generic name revefenacin, and it is a long-acting muscarinic antagonist (LAMA) used in the treatment of chronic obstructive pulmonary disease (COPD).